Transitioning to E-Cigarettes Aids Resolution of Respiratory Symptoms

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

TUESDAY, Nov. 12, 2024 -- Transitioning from cigarettes to electronic cigarettes (e-cigarettes) is associated with resolution of respiratory symptoms, but the rate of resolution is reduced among those who switch to dual use or maintain or increase smoking intensity, according to a study published online Nov. 12 in Nicotine & Tobacco Research.

Jonathan B. Berlowitz, M.D., from the Boston University School of Public Health, and colleagues examined whether transitioning from cigarettes to e-cigarettes is associated with resolution of respiratory symptoms using data from the Population Assessment of Tobacco and Health (PATH) study waves 1 to 5. Observations with cigarette−e-cigarette exposure intervals determined from PATH waves 1 to 2, 2 to 3, and 3 to 4 were included for participants who reported exclusively smoking at baseline and reported a baseline cough or wheeze.

The researchers found that compared with persistent smoking, transitioning from cigarettes to e-cigarettes was associated with increased rates of wheeze resolution (incidence rate ratio, 1.33; 95 percent confidence interval, 1.01 to 1.75), but not with cough resolution (incidence rate ratio, 1.18; 95 percent confidence interval, 0.93 to 1.50) among 5,210 observations. There was no association seen for cigarette to dual-use transitions with improvements in symptom resolution. Compared with persistent smoking, whose who switched to dual use and maintained or increased their smoking intensity had 15 percent reduced rates of respiratory symptom resolution.

"Whereas cigarette users who switch completely to e-cigarettes may experience respiratory symptom improvements, those unable to reduce their smoking intensity may face increased risk of respiratory morbidity," the authors write. "This difference is concerning as U.S. cigarette users are far more likely to transition to dual use than to exclusive e-cigarette use."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-11-13 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords